User profiles for "author:Seyed Mohammad Baghbanian"
Seyed Mohammad BaghbanianAssociate Professor Of Neurology, Faculty of Medicine, Mazandaran University Of Medical Verified email at mazums.ac.ir Cited by 517 |
Diagnosis and management of neuromyelitis optica spectrum disorder (NMOSD) in Iran: a consensus guideline and recommendations
MA Sahraian, AN Moghadasi, AR Azimi… - Multiple sclerosis and …, 2017 - Elsevier
Abstract Neuromyelitis Optica Spectrum Disorder (NMOSD) is a relapsing neuro
inflammatory disease of the central nervous system that typically presents with optic neuritis …
inflammatory disease of the central nervous system that typically presents with optic neuritis …
A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment
SM Baghbanian, N Asgari, MA Sahraian… - Journal of the …, 2018 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disorder
of the central nervous system (CNS). Serum immunoglobulin G autoantibodies (NMO-IgG) …
of the central nervous system (CNS). Serum immunoglobulin G autoantibodies (NMO-IgG) …
Post COVID-19 longitudinally extensive transverse myelitis (LETM)–a case report
SM Baghbanian, F Namazi - Acta Neurologica Belgica, 2021 - Springer
Dear editor A 53-year-old female was admitted to the neurology ward of Booalisina hospital
Sari, Iran after suffering from paraparesis for 2 days. The patient's symptoms started with …
Sari, Iran after suffering from paraparesis for 2 days. The patient's symptoms started with …
Multiple sclerosis national registry system in Iran: validity and reliability of a minimum data set
Background As the prevalence and incidence of Multiple Sclerosis (MS) are increasing
remarkably in Iran, gathering standardized information regarding the individual's diagnosis …
remarkably in Iran, gathering standardized information regarding the individual's diagnosis …
[HTML][HTML] Epidemiology of familial multiple sclerosis in Iran: a national registry-based study
Background Admittedly, little is known about the epidemiological signatures of familial
multiple sclerosis (FMS) in different geographical regions of Iran. Objective To determine the …
multiple sclerosis (FMS) in different geographical regions of Iran. Objective To determine the …
Ischemic stroke associated with novel coronavirus 2019: a report of three cases
A Sharifi-Razavi, N Karimi, A Zarvani… - International Journal …, 2021 - Taylor & Francis
Introduction There is limited evidence about the neurological manifestations of COVID-19 in
infected patients. In this report, we describe three patients with ischemic stroke associated …
infected patients. In this report, we describe three patients with ischemic stroke associated …
Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics
Background Today, it is estimated that around 5% of multiple sclerosis (MS) patients are in
the late-onset category (age at disease onset≥ 50). Diagnosis and treatment in this group …
the late-onset category (age at disease onset≥ 50). Diagnosis and treatment in this group …
[HTML][HTML] Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study
H Cheraghmakani, SM Baghbanian, R HabibiSaravi… - PloS one, 2020 - journals.plos.org
Introduction The incidence rate of MS is a valuable indicator of the recent changes in the risk
of this disease, and it is widely implicated for health planning purposes. Objectives This …
of this disease, and it is widely implicated for health planning purposes. Objectives This …
Therapeutic use of intrathecal mesenchymal stem cells in patients with multiple sclerosis: a pilot study with booster injection
MA Sahraian, M Mohyeddin Bonab… - Immunological …, 2019 - Taylor & Francis
ABSTRACT Background: Mesenchymal stem cells (MSCs) are a potential therapy for
various diseases. Here, the results of intrathecal injection of MSCs in multiple sclerosis (MS) …
various diseases. Here, the results of intrathecal injection of MSCs in multiple sclerosis (MS) …
Characteristics of COVID-19 in patients with multiple sclerosis
F Ghadiri, MA Sahraian, V Shaygannejad… - Multiple sclerosis and …, 2022 - Elsevier
Background Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran,
a multicenter study of COVID-19 in Iranian MS patients with is carried out to address the …
a multicenter study of COVID-19 in Iranian MS patients with is carried out to address the …